|
HS Code |
141619 |
| Product Name | 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid |
| Cas Number | 864377-24-2 |
| Molecular Formula | C7H7BBrFO2 |
| Molecular Weight | 231.85 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 108-112°C |
| Purity | Typically ≥97% |
| Synonyms | 5-Bromo-2-fluoro-m-tolylboronic acid |
| Smiles | B(C1=CC(=C(C=C1F)C)Br)(O)O |
| Storage Conditions | Store at 2-8°C, protected from moisture |
| Solubility | Slightly soluble in water; soluble in DMSO and organic solvents |
| Application | Used in Suzuki-Miyaura cross-coupling reactions |
As an accredited 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Basic building blocks drive innovation in chemical synthesis. In my years working with boronic acids, I’ve noticed that small tweaks in molecular structure transform function. 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid stands out thanks to its well-considered combination of bromo, fluoro, and methyl groups on the phenyl ring. Each group changes the molecule’s reactivity in its own way, which makes this compound a popular choice for synthetic chemists working on novel pharmaceuticals or advanced materials. Understanding these details makes a real difference in research success, especially during late-stage derivatization or optimization of lead compounds.
The bromo atom at the 5-position means this boronic acid brings good leaving group potential and enables Suzuki-Miyaura coupling reactions with ease. Adding a fluorine at the 2-position often increases metabolic stability in drug candidates—a big deal for anyone hoping to improve oral bioavailability and half-life. The methyl group at the 3-position affects electron distribution along the phenyl ring, shifting both steric profile and electronic properties, which has a downstream effect on binding affinity in target molecules or final material performance. Each of these features comes with scientific intent, targeting known hurdles in both discovery chemistry and real-world pharmaceutical development.
From my experience, 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid quietly solves problems. Reactions that stumble on steric congestion around unsubstituted phenylboronic acids can often be rescued here thanks to the methyl group’s effect on geometry and reactivity. I once worked on a series of kinase inhibitors where a simple phenylboronic acid derivative just couldn’t add functional diversity during coupling steps without unwanted byproducts. Substituting in this molecule led to higher conversion and cleaner isolations, minimizing purification effort. The selectivity and yield jump mirrored findings in academic papers, which credit the same blend of functional groups.
In contrast with similar boronic acids lacking the fluorine or bromo atoms, I’ve found the cross-coupling reactions run cleaner and are less prone to protodeboronation, even in slightly wet conditions. That saves precious starting materials and reduces waste, important in both research-scale chemistry and process development. Everyone in the lab benefits when a boronic acid brings both better performance and greater reliability.
Fluorinated groups have a well-documented history of improving the pharmacokinetic properties of compounds. The 2-fluoro group handles metabolic hotspots, reducing the chance that liver enzymes will chew up a candidate compound too quickly. This modification provides medicinal chemists more leeway to explore biological activity without getting tripped up by fast clearance rates. In smaller molecule design, this boronic acid forms the backbone for new analogs of high-value targets in oncology, neurology, and anti-infectives. Adding a methyl at the 3-position further adjusts lipophilicity, a consideration for anyone trying to balance target affinity with membrane permeability.
For process chemists, product stability stands out as another clear advantage. Some boronic acids suffer from hydrolysis during storage or project delays. Here, the electronic effects of fluoro and methyl groups on the aromatic ring help protect the boron-carbon bond, extending shelf life under standard laboratory conditions. Less material loss in storage means lower costs and faster timelines, which always earns appreciation from project managers.
Anyone who has ordered, stored, and handled a range of phenylboronic acids knows they can vary greatly in performance—even when their chemical formulae look similar at first glance. Compare this compound to a basic phenylboronic acid: it withstands harsh reaction conditions better, especially under slightly basic or wet Suzuki coupling protocols. Many chemists find that a 5-bromo group makes cross-coupling easier by acting as a strategic handle for further substitution down the line—a big help while building libraries of analogs for structure-activity relationship (SAR) work.
Unlike plain 2-fluorophenylboronic acid, which sometimes struggles with solubility or undesired reactivity, the added methyl shifts properties just enough to allow cleaner isolation without creating extra synthetic headaches. For those working on complex target synthesis, this means fewer surprises and less troubleshooting. These are not “invisible” benefits; they shape which molecules reach the stage of full biological evaluation and, in some cases, which projects succeed.
Research groups in pharmaceutical and biotech companies routinely adopt boronic acids as key tools. 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid finds use mainly in Suzuki reactions—a bread-and-butter method for linking aromatic fragments. Anyone synthesizing kinase inhibitors, proteasome inhibitors, or boron-containing sensor molecules will see gains. The compound has also found its way into material science, where tailored aromatic frameworks help create advanced polymers and light-emitting materials.
In my own teaching, I encourage students to connect the dots between chemical structure and downstream impact, not just reaction feasibility. Using this molecule as an example, we follow its journey from synthesis—usually through lithiation-borylation or palladium-catalyzed borylation—into real targets: drugs, imaging agents, new materials. It helps students see that placing a bromine here, a fluorine there, looks like art but comes from years of research understanding enzyme action, metabolic resistance, and even cross-disciplinary needs like light absorption for photonic devices.
Labs need reliable materials. I’ve stored this boronic acid months at a time, with only minimal precautions—dry storage and away from harsh oxidizers. The added stability from its substituents reduces frustrating losses from decomposition, even compared with “shelf-stable” alkylboronic acids. If you care about minimizing restocking runs or waste disposal, these small structural tweaks truly pay off.
On the benchtop, the powder handles easily, with low clumping and no troublesome static. Researchers enjoy spending less time coaxing material into solution and more time building the next fragment library. The physical behavior also helps with automated synthesis platforms, which increasingly drive success in modern drug discovery or materials innovation.
High-purity boronic acids make collaborative research move faster. Nobody wants to rerun reactions or screen impurities instead of intended products. Purity above 98% brings confidence to those running precision organometallic reactions or engaging in scale-up efforts. It's also worth considering batch consistency, which matters for regulatory or GMP environments weaving this boronic acid into clinical candidate synthesis.
Many commercial suppliers now offer this molecule in various pack sizes. I’ve found it available in both research and process development quantities, which means less time spent chasing exotic intermediates or worrying about supply chain bottlenecks. As industry moves toward more “boron-forward” design, reliable sources empower new discoveries.
Working with specialty boronic acids brings its own list of obstacles: occasional supply constraints, batch-to-batch variability, or environmental considerations from manufacturing. It pays off to verify supplier transparency, check for up-to-date COAs, and—where possible—review independent analyses from trusted partners or your own lab. Maintaining open communication lines with suppliers and colleagues helps everyone preempt slowdowns.
Rather than relying only on legacy literature, be ready to test a few reaction conditions. Slight changes—base strength, catalyst choice, solvent selection—can unlock maximum performance. In one project, switching to a less basic aqueous-organic solvent mixture improved conversion dramatically, proving again that even small tweaks pay dividends when using structurally advanced boronic acids.
Green chemistry grows in importance as regulations tighten and companies pursue sustainability. Boronic acid reactions generate less hazardous waste compared to some alternative coupling methods. The inherent selectivity of 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid reduces unwanted side reactions and streamlines purification, cutting down on solvent use and associated disposal costs.
Some groups have published on recyclable catalyst systems, which pair well with robust boronic acids. Advances in process chemistry continue to reduce the environmental impact of cross-couplings, helping academic and industry teams meet internal and regulatory expectations. Cheaper, faster, and cleaner syntheses represent a win for everyone from bench chemists to community stakeholders.
Discovery rarely happens in isolation. One benefit of using a versatile boronic acid is broader collaboration across chemistry, biology, and material science teams. Researchers draw on each other’s experiences, troubleshooting and improving synthetic steps together. I’ve witnessed entire teams expedite hit-to-lead projects by agreeing on a handful of reliable building blocks. This compound consistently shows up on those lists, saving time and energy for more demanding bench challenges.
In my academic circles, feedback on this molecule points to fewer failed couplings and more freedom to design creative libraries. Teams working to develop chemical probes, diagnostics, or imaging agents turn to this building block for the flexibility it introduces in structure-activity relationships. Such feedback underscores the real value that comes from practical reliability and well-understood reactivity.
Pharmaceutical chemistry often revolves around fine-tuning molecular structure—sometimes by just one functional group. In a published case on kinase inhibitor development, switching from standard phenylboronic acid to a difluorinated, brominated analog led to a tenfold improvement in cell-based potency. Importantly, metabolic stability jumped, lowering the metabolic clearance rate in human liver microsome assays. This kind of real laboratory evidence shows why thoughtful substitution pays off at both the bench and the clinic.
Another team building OLED materials found that boronic acids packed with electron-donating and -withdrawing groups gave better spectral properties when building aromatic polymers. The extra methyl group on this boronic acid contributed just enough electronic push to shift emission wavelengths and enhance brightness stability. Direct feedback from end users drove more attention toward substitution patterns that balance reactivity and durability—a problem solved in part by tuning which boronic acids join the party.
While some chemical intermediates fall out of fashion, boronic acids keep their place in both academic labs and industry. As automated and high-throughput platforms spread, chemists value reagents that don’t disrupt screens with side reactions or solubility problems. The reputation this boronic acid carries for consistent performance and cleaner workups portends even broader adoption.
Anyone stepping into the medicinal chemistry landscape should pay attention to these humble but high-impact building blocks. Future trends point toward more customized synthesis where researchers configure their own versions of boronic acids to match biological targets or material requirements. Expect to see more work unraveling how each substituent—bromo, fluoro, methyl—aims for a specific balance of reactivity, stability, and function. In practice, it’s the incremental improvements that make discovery faster, cleaner, and more rewarding.
Looking back on projects involving 5-Bromo-2-Fluoro-3-Methylphenylboronic Acid, the compound wins by combining classic boronic acid utility with a modern understanding of structure-function relationships. Its balanced set of functional groups enable both reliable reactivity and nuanced property tuning, supporting innovation in medicinal chemistry and material science alike. Well-designed molecules don’t just exist for textbooks—they make daily lab work easier, research programs more ambitious, and final products more effective.
Building a more innovative research future calls for molecular tools that deliver every time they’re pulled off the shelf. My own experience, shared by dozens of researchers I’ve trained and collaborated with, shows that this boronic acid deserves its strong reputation among today’s most valuable synthetic building blocks. Whether crafting the next generation of medicines, tuning high-tech materials, or teaching future chemists, it pays to know which tools just work—day in and day out.